Title:
ＩＬ−１β関連疾患の治療方法
Document Type and Number:
Japanese Patent JP5856667
Kind Code:
B2
Abstract:
Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, obesity, hyperglycemia, hyperinsulinemia and Type 1 diabetes, comprising administering to a subject an effective amount of anti-IL-1² antibody or fragment thereof.
Inventors:
Solinger Alan
Bower Robert Jay.
Scannon Patrick Jay.
All Ever David
Bower Robert Jay.
Scannon Patrick Jay.
All Ever David
Application Number:
JP2014224090A
Publication Date:
February 10, 2016
Filing Date:
November 04, 2014
Export Citation:
Assignee:
Zoma (US) Limited Liability Company
International Classes:
A61K39/395; A61P3/10
Domestic Patent References:
| JP2004506448A | ||||
| JP2004502428A | ||||
| JP2005534677A | ||||
| JP2008543340A |
Foreign References:
| WO2007042524A1 | ||||
| WO2007002261A2 |
Other References:
CAILLEAU C,DIABETES,米国,1997年 6月,V46 N6,P937-940
Ann. N.Y. Acad. Sci., 2006.11, Vol.1084, pp.89-117
Ann. N.Y. Acad. Sci., 2006.11, Vol.1084, pp.89-117
Attorney, Agent or Firm:
Hatsushi Shimizu
Masao Haruna
Hirotaka Yamaguchi
Toshi Gobe
Ryuichi Inoue
Toshimitsu Sato
Koichi Niimi
Tomohiko Kobayashi
Masato Ozeki
Yoshihiro Igarashi
Kazuya Kawamoto
Masao Haruna
Hirotaka Yamaguchi
Toshi Gobe
Ryuichi Inoue
Toshimitsu Sato
Koichi Niimi
Tomohiko Kobayashi
Masato Ozeki
Yoshihiro Igarashi
Kazuya Kawamoto